Expanded Treatment Options with Direct Oral Anticoagulants (DOACs)

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Pharmacists

Description

This knowledge-based CPE activity will provide the healthcare professional with an understanding of the role of the Direct Acting Oral Anticoagulants (DOACs) expanded indications for special patient populations. This is live webinar only. Instructors will present remotely.

Webinar Information

Live Webinar Information
This webinar will be broadcast with Zoom. Instructions to join the webinar will be emailed prior to the event. Please go to our live webinar requirements page for more information and to test the computer/device and network prior to the event.


Continuing Education Credit For Pharmacists:
The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE#0046-9999-20-232-L01-P XXXXXXXXX (Pharmacist)and (Pharmacy Technician) provides 2.0 contact hours of continuing pharmacy education credit. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks. **No partial credit will be available**

Objectives

• Discuss current practice with the expanded use of DOACs in patients with CAD
• Identify appropriate treatment recommendations based on available clinical studies and guidelines for the available DOACs
• Examine available data for the use of DOACs for the treatment of VTE in patients with active cancer
• Summarize available literature of DOACs in patients with a Left Ventricular thrombus

Contact

Sarah Ashcraft BA

Sessions